Table 2.
Respiratory pathogen | Negative SARS-CoV-2 HCWs (n = 241) N (%) |
Positive SARS-CoV-2 HCWs (n = 66) N (%) |
---|---|---|
Coronavirus SARS-CoV-2 | 0 (0) | 66 (100) |
Samples with detection of at least one respiratory virus (excluding SARS-CoV-2) | 44 (18.26) | 6 (9.09) |
Adenovirus | 15 (6.22) | 2 (3.03) |
Coronavirus 229E | 0 (0) | 0 (0) |
Coronavirus HKU1 | 2 (0.83) | 0 (0) |
Coronavirus NL63 | 5 (2.07) | 0 (0) |
Coronavirus OC43 | 0 (0) | 0 (0) |
Human metapneumovirus | 1 (0.41) | 0 (0) |
Human rhinovirus/enterovirus | 27 (11.20) | 3 (4.55) |
Influenzavirus A | 0 (0) | 0 (0) |
Influenzavirus B | 0 (0) | 0 (0) |
MERS-CoV | 0 (0) | 0 (0) |
Parainfluenza virus 1 | 0 (0) | 0 (0) |
Parainfluenza virus 2 | 3 (1.24) | 2 (3.03) |
Parainfluenza virus 3 | 0 (0) | 0 (0) |
Parainfluenza virus 4 | 1 (0.41) | 0 (0) |
Respiratory syncytial virus | 4 (1.66) | 0 (0) |
Samples with detection of at least one bacterium | 3 (1.24) | 0 (0) |
Bordetella parapertussis | 0 (0) | 0 (0) |
Bordetella pertussis | 0 (0) | 0 (0) |
Chlamydia pneumoniae | 2 (0.83) | 0 (0) |
Mycoplasma pneumoniae | 1 (0.41) | 0 (0) |
No significant statistical difference (p-value > 0.05) was observed between samples tested negative or positive by SARS-CoV-2 RT-PCR.